Review
doi: 10.1586/ehm.09.21.
PET imaging in lymphoma
Affiliations
- PMID: 21082968
- DOI: 10.1586/ehm.09.21
Item in Clipboard
Review
PET imaging in lymphoma
Expert Rev Hematol.
2009 Jun.
Abstract
PET has become a cornerstone procedure in modern lymphoma management. This paper reviews, from a clinical point of view, the evidence for using PET in the different subtypes of lymphoma and the different steps of their management. The reader is given an overview of the current PET-based interventional lymphoma trials and an insight into possible future developments in the field, including new PET tracers.
Similar articles
-
New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma.Radiol Clin North Am. 2008 Mar;46(2):213-23, vii. doi: 10.1016/j.rcl.2008.03.003. Radiol Clin North Am. 2008. PMID: 18619377
-
The role of PET imaging in lymphoma.Br J Haematol. 2004 Sep;126(6):772-84. doi: 10.1111/j.1365-2141.2004.05069.x. Br J Haematol. 2004. PMID: 15352980 Review.
-
The use of positron emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) in Hodgkin and non-Hodgkin's lymphoma.Hematology. 2003 Dec;8(6):403-8. doi: 10.1080/1024533032000158841. Hematology. 2003. PMID: 14668036
-
Imaging of non-Hodgkin lymphomas: diagnosis and response-adapted strategies.Cancer Treat Res. 2015;165:125-46. doi: 10.1007/978-3-319-13150-4_5. Cancer Treat Res. 2015. PMID: 25655608 Review.
-
2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas.Semin Radiat Oncol. 2007 Jul;17(3):190-7. doi: 10.1016/j.semradonc.2007.02.005. Semin Radiat Oncol. 2007. PMID: 17591566 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
